Poor Antigen Processing of Poxvirus Particles Limits CD4


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 09 08 2018
accepted: 27 12 2018
pubmed: 1 2 2019
medline: 13 11 2019
entrez: 1 2 2019
Statut: ppublish

Résumé

CD4

Identifiants

pubmed: 30700590
pii: jimmunol.1801099
doi: 10.4049/jimmunol.1801099
pmc: PMC6394857
mid: NIHMS1517683
doi:

Substances chimiques

Vaccines, Inactivated 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1340-1349

Subventions

Organisme : NCI NIH HHS
ID : F31 CA206338
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400045C
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI110542
Pays : United States

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Références

Clin Infect Dis. 2014 Jan;58(2):260-7
pubmed: 24158414
J Gen Virol. 2003 Sep;84(Pt 9):2293-2303
pubmed: 12917449
Can Med Assoc J. 1966 Jun 18;94(25):1316-7
pubmed: 5947200
Nat Med. 2015 Oct;21(10):1216-22
pubmed: 26413780
J Immunol. 2005 Nov 15;175(10):6829-36
pubmed: 16272340
Clin Vaccine Immunol. 2008 Feb;15(2):348-58
pubmed: 18057181
J Virol. 2000 Jun;74(11):4999-5005
pubmed: 10799573
Arch Virol. 1989;107(1-2):35-41
pubmed: 2803004
Virology. 2007 Feb 5;358(1):233-47
pubmed: 17005230
Front Immunol. 2013 Dec 16;4:464
pubmed: 24379819
BMC Bioinformatics. 2010 Nov 22;11:568
pubmed: 21092157
Vaccine. 2005 Jul 14;23(32):4185-7
pubmed: 15916840
J Immunol. 2007 Jun 15;178(12):7890-901
pubmed: 17548627
J Virol. 2014 Sep 1;88(17):10078-91
pubmed: 24965457
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5
pubmed: 18245380
Lab Anim Sci. 1987 Feb;37(1):23-7
pubmed: 3035275
Am Fam Physician. 2003 Sep 1;68(5):889-96
pubmed: 13678138
Crit Rev Ther Drug Carrier Syst. 1999;16(1):1-83
pubmed: 10099898
J Virol. 2016 Oct 14;90(21):9905-9919
pubmed: 27558425
J Exp Med. 1989 Mar 1;169(3):921-31
pubmed: 2784481
PLoS One. 2011;6(9):e25396
pubmed: 21980444
Mil Med. 2013 Dec;178(12):e1375-8
pubmed: 24306023
Emerg Infect Dis. 2011 Apr;17(4):730-3
pubmed: 21470473
J Immunol. 1994 May 15;152(10):4884-92
pubmed: 7513725
J Gen Virol. 2004 Jan;85(Pt 1):105-117
pubmed: 14718625
J Infect Dis. 2011 Jan 1;203(1):95-102
pubmed: 21148501
Bull World Health Organ. 1975;52(1):51-6
pubmed: 1082382
Methods Mol Biol. 2004;269:243-66
pubmed: 15114020
Vaccine. 2010 Sep 14;28(40):6627-36
pubmed: 20659519
J Infect Dis. 1982 Jul;146(1):47-51
pubmed: 6282993
J Gen Virol. 1971 Oct;13(1):19-25
pubmed: 5130569
Vet Microbiol. 2017 May;204:84-89
pubmed: 28532811
Immunology. 1986 Oct;59(2):261-7
pubmed: 3490436
PLoS Pathog. 2013;9(12):e1003756
pubmed: 24339772
Virologie. 1976 Jul-Sep;27(3):173-7
pubmed: 1006976
J Immunol. 2003 Apr 1;170(7):3504-13
pubmed: 12646611
J Exp Med. 1996 Feb 1;183(2):403-11
pubmed: 8627153
Mil Med. 2011 Jun;176(6):699-701
pubmed: 21702392
J Virol. 2012 Nov;86(21):11533-40
pubmed: 22896601
Front Immunol. 2017 Mar 14;8:278
pubmed: 28352270
J Gen Microbiol. 1962 Nov;29:523-9
pubmed: 14004140
MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28
pubmed: 12617510
Cell Immunol. 1996 Mar 15;168(2):184-92
pubmed: 8640864
Cell. 2016 Oct 20;167(3):684-694.e9
pubmed: 27768891
Immunology. 2018 Jul;154(3):394-406
pubmed: 29315598
Proc (Bayl Univ Med Cent). 2005 Jan;18(1):21-5
pubmed: 16200144
mBio. 2013 Nov 05;4(6):e00812-13
pubmed: 24194540
Adv Immunol. 2016;129:251-76
pubmed: 26791861
J Virol. 2007 May;81(10):4928-40
pubmed: 17329346
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9983-8
pubmed: 22665800
Clin Med Res. 2003 Apr;1(2):87-92
pubmed: 15931293
J Immunol. 2006 Aug 15;177(4):2552-64
pubmed: 16888017
J Gen Virol. 2005 Oct;86(Pt 10):2645-2659
pubmed: 16186218
Vaccine. 2009 Dec 30;27 Suppl 6:G21-6
pubmed: 20006135
Future Microbiol. 2010 Feb;5(2):221-39
pubmed: 20143946
Nat Immunol. 2005 Mar;6(3):287-94
pubmed: 15711549

Auteurs

Katherine S Forsyth (KS)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Brian DeHaven (B)

Department of Biology, La Salle University, Philadelphia, PA 19141.

Mark Mendonca (M)

Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107.

Sinu Paul (S)

La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.

Alessandro Sette (A)

La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037.
Department of Medicine, University of California, San Diego, La Jolla, CA, 92093; and.

Laurence C Eisenlohr (LC)

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; eisenlc@pennmedicine.upenn.edu.
Children's Hospital of Philadelphia, Philadelphia, PA 19104.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH